E-LIB Suche - Ergebnisse für: Bono, S.

1

79MO Developing international consensus-driven SPIRIT and C..:

Solovyeva, O. ; Dimairo, M. ; Weir, C....
ESMO Open. 8 (2023) 1 - p. 100937 , 2023

Link: https://doi.org/10.1016/..

2

What is the impact of targeted therapies given within phase..:

Stapleton, Sarah ; Darlington, Anne-Sophie Emma ; de Bono, J S.
BMJ Open. 12 (2022) 11 - p. e050590 , 2022

Link: https://doi.org/10.1136/..

3

KEYNOTE-365 cohort D: Pembrolizumab (pembro) plus abiratero..:

Todenhöfer, T. ; Piulats, J.M. ; Ferrario, C....
European Urology. 81 (2022) - p. S789-S790 , 2022

Link: https://doi.org/10.1016/..

4

Patient-reported pain by baseline pain status in men with m..:

Stenzl, A. ; Saad, F. ; De Bono, J.S....
European Urology Open Science. 33 (2021) - p. S308-S309 , 2021

Link: https://doi.org/10.1016/..

5

Health-Related Quality of Life (HRQoL) in men with metastat..:

Stenzl, A. ; Saad, F. ; De Bono, J.S....
European Urology Open Science. 33 (2021) - p. S198-S199 , 2021

Link: https://doi.org/10.1016/..

6

Pembrolizumab (pembro) for docetaxel-pretreated metastatic ..:

Piulats, J.M. ; Antonarakis, E.S. ; Gross-Goupil, M....
European Urology Open Science. 19 (2020) - p. e877-e878 , 2020

Link: https://doi.org/10.1016/..

7

KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus en..:

McDermott, R. ; Graff, J.N. ; Antonarakis, E.S....
European Urology Open Science. 19 (2020) - p. e885-e886 , 2020

Link: https://doi.org/10.1016/..

8

A phase I dose-escalation study of enzalutamide in combinat..:

Kolinsky, M.P. ; Rescigno, P. ; Bianchini, D....
Annals of Oncology. 31 (2020) 5 - p. 619-625 , 2020

Link: https://doi.org/10.1016/..

9

The role of abiraterone acetate plus prednisone/prednisolon..:

Hoyle, A.P. ; Ali, A. ; James, N.D....
European Urology Supplements. 18 (2019) 1 - p. e1387-e1388 , 2019

Link: https://doi.org/10.1016/..

10

Management of patients with advanced prostate cancer: recom..:

Gillessen, S. ; Omlin, A. ; Attard, G....
Annals of Oncology. 30 (2019) 12 - p. e3 , 2019

Link: https://doi.org/10.1093/..

11

A decade of clinical development of PARP inhibitors in pers..:

Mateo, J. ; Lord, C.J. ; Serra, V....
Annals of Oncology. 30 (2019) 9 - p. 1437-1447 , 2019

Link: https://doi.org/10.1093/..

12

Circulating tumour cell increase as a biomarker of disease ..:

Lorente, D. ; Olmos, D. ; Mateo, J....
Annals of Oncology. 29 (2018) 7 - p. 1554-1560 , 2018

Link: https://doi.org/10.1093/..

13

The stress relaxation (creep) rate of Mu2e straw tubes:

Bono, J.S. ; Caron, J.-F. ; Oh, S.H..
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 902 (2018) - p. 95-102 , 2018

Link: https://doi.org/10.1016/..

14

Vistusertib (dual m-TORC1/2 inhibitor) in combination with ..:

Basu, B. ; Krebs, M.G. ; Sundar, R....
Annals of Oncology. 29 (2018) 9 - p. 1918-1925 , 2018

Link: https://doi.org/10.1093/..

15

Adding abiraterone or docetaxel to long-term hormone therap..:

Sydes, M.R. ; Spears, M.R. ; Mason, M.D....
Annals of Oncology. 29 (2018) 5 - p. 1235-1248 , 2018

Link: https://doi.org/10.1093/..